✦ LIBER ✦

5020 Pharmacokinetics (PK), safety, and efficacy of trastuzumab (T)-DM1, a HER2 antibody-drug conjugate (ADC), in patients with HER2+ metastatic breast cancer (MBC): phase I and phase II trial results

✍ Scribed by H. Burris III; S. Vukelja; I. Krop; S. Modi; B. Klencke; S. Girish; M.X. Sliwkowski; M. Dresser; G.L. Phillips; H. Rugo

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

2118 POSTER A phase I study of trastuzum

✍ I.E. Krop; M. Beeram; S. Modi; N. Rabbee; S. Girish; J. Tibbitts; S.N. Holden; S 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 58 KB

A Phase I/II Trial of Trastuzumab and Ge

✍ Stacy L. Moulder; Carlos L. Arteaga 📂 Article 📅 2003 🏛 CIG Media Group, LP. 🌐 English ⚖ 440 KB

A phase II trial to assess efficacy and

✍ Martin Schuler, Ahmad Awada, Philipp Harter, Jean Luc Canon, Kurt Possinger, Mar 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 303 KB

A phase I/II prospective, single arm tri

✍ G. Somlo; C. L. Martel; S. K. Lau; P. Frankel; C. Ruel; L. Gu; A. Hurria; C. Chu 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 229 KB

Efficacy and safety of three-weekly herc

✍ S. Verma; B. Leyland-Jones; J.-P. Ayoub; K. Gelmon; A. Arnold; C. Szakacs; J. Ho 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 173 KB

Phase II evaluation of the efficacy and

✍ J. Cortes; K. Gelmon; P. Fumoleau; A. Wardley; S. Verma; P.F. Conte; L. Gianni; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 58 KB